Victor Levin[Author] - Search Results

Year	Number of Results
2002	5
2003	9
2004	9
2005	1
2006	4
2007	5
2008	5
2009	1
2010	6
2011	6
2012	5
2013	2
2014	2
2015	4
2016	1
2017	3
2018	4
2019	1
2020	3
2022	2
2024	0

1

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF. Levin VA, et al. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1487-95. doi: 10.1016/j.ijrobp.2009.12.061. Int J Radiat Oncol Biol Phys. 2011. PMID: 20399573 Free PMC article. Clinical Trial.

2

How far will the Voyager^® take us?

Levin VA. Levin VA. CNS Oncol. 2019 Mar;8(1):CNS26. doi: 10.2217/cns-2018-0019. Epub 2019 Feb 15. CNS Oncol. 2019. PMID: 30767555 Free PMC article. No abstract available.

3

Drug discovery in neuro-oncology: challenges in the path forward.

Levin VA. Levin VA. Neuro Oncol. 2018 Mar 27;20(4):435-436. doi: 10.1093/neuonc/noy004. Neuro Oncol. 2018. PMID: 29538691 Free PMC article. No abstract available.

4

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas.

Levin VA, Ictech SE, Hess KR. Levin VA, et al. CNS Oncol. 2018 Apr;7(2):CNS16. doi: 10.2217/cns-2017-0031. Epub 2018 Jan 30. CNS Oncol. 2018. PMID: 29378419 Free PMC article. Review.

5

Cyclooxygenase-2 inhibitors in glioma therapy.

Giglio P, Levin V. Giglio P, et al. Among authors: levin v. Am J Ther. 2004 Mar-Apr;11(2):141-3. doi: 10.1097/00045391-200403000-00009. Am J Ther. 2004. PMID: 14999366 Review.

6

Understanding brain penetrance of anticancer drugs.

Levin VA, Ellingson BM. Levin VA, et al. Neuro Oncol. 2018 Apr 9;20(5):589-596. doi: 10.1093/neuonc/noy018. Neuro Oncol. 2018. PMID: 29474640 Free PMC article.

7

Are gliomas preventable?

Levin VA. Levin VA. Recent Results Cancer Res. 2007;174:205-15. doi: 10.1007/978-3-540-37696-5_18. Recent Results Cancer Res. 2007. PMID: 17302198 Review.

8

Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.

Clarke JW, Chang EL, Levin VA, Mayr NA, Hong E, Cavaliere R, Lo SS. Clarke JW, et al. Among authors: levin va. Expert Rev Anticancer Ther. 2008 May;8(5):733-41. doi: 10.1586/14737140.8.5.733. Expert Rev Anticancer Ther. 2008. PMID: 18471046 Review.

9

Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome.

Karmur BS, Philteos J, Abbasian A, Zacharia BE, Lipsman N, Levin V, Grossman S, Mansouri A. Karmur BS, et al. Among authors: levin v. Front Oncol. 2020 Sep 18;10:563840. doi: 10.3389/fonc.2020.563840. eCollection 2020. Front Oncol. 2020. PMID: 33072591 Free PMC article. Review.

10

Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.

Kyritsis AP, Bondy ML, Levin VA. Kyritsis AP, et al. Among authors: levin va. Nutr Cancer. 2011;63(2):174-84. doi: 10.1080/01635581.2011.523807. Nutr Cancer. 2011. PMID: 21302177 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year